Pharm - Urinary Incontinence Flashcards
What are the goals of therapy for urge incontinence?
- reduce avg # of urinary incontinence episodes per day
- decrease # of micturition per day
- increase urine volume voided per micturition
- improve quality of life
MOA of antimuscarinics for tx of urinary incontinence
Antagonize muscarinic receptors and suppress mature detrusor contractions, enhance bladder storage
MOA of mirabegron (Myrbetriq) for tx of urinary incontinence
- B2-adrenergic agonist
- beta-e receptors play role in relaxing smooth muscle in the bladder
- increases bladder capacity by relaxing the detrusor muscle during storage phase of urinary bladder fill-void cycle by activation of B3-adrenergic receptors
ADR of antimuscarinic drugs
- related to anticholinergic activity: dry mouth, constipation, HA, dry eyes, blurred vision, cognitive impairment, tachycardia, sedation, orthostatic hypotension
- topicals: erythema, pruritus at application site
Contraindications to antimuscarinic drugs
- urinary retention, gastric retention, severely decreased GI motility, angioedema, myasthenia gravis, uncontrolled narrow angle glaucoma
- mental status changes (risk of fall in elderly or frail)
- worsening renal/hepatic condition
1st generation antimuscarinic agents used to treat urinary incontinence
1st gen: oxybutynin, tolterodine, fesoterodine
2nd generation antimuscarinic agents used to treat urinary incontinence
2nd gen: trospium, solifenacin, darifenacin
*these are less likely to impact CNS
Role of vaginal estrogens in tx of stress incontinence
Used in peri- or post-menopausal women with either stress or urgency incontinence and vaginal atrophy
- best dosage form is topical
- may take up to 3 months to notice benefit
Tx for urinary incontinence
- 1st line is lifestyle
- in stress UI: pelvis floor muscle training, NOT systemic pharm
- for mixed UI: pelvis floor training with bladder training
- for urgency UI: pharm management if bladder training unsuccessful
- weight loss and exercise are recommended
Urgency UI pharm management
- anticholinergic/antimuscarinic are 1st line
- Mirabegron is an alternative for pts who can’t tolerate 1st line or have contraindications to them
Contraindications for urinary incontinence products
Antimuscarinics: all products interact with potent CYP3A4 products (ketoconazole, itraconazole, clarithromycin, ritonavir)
Mirabegron: do NOT use in patients with severe or uncontrolled HTN.